- Filed
- Jun 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 7.95M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 5.53M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 2.92M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$190K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$15K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $72K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $57K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$3.43M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$3.95M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$3.55M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$3.17M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.31M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.91M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.31M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.91M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $832K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $841K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $884K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $962K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.09 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.15 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.15 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $333K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $283K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$497K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$399K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$333K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$283K |